Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy and learning disabilities

This publication has 10 references indexed in Scilit:

• Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients
  Seizure, 2003
• Efficacy of levetiracetam in developmentally disabled patients: a review of the literature and six case reports
  Epilepsy & Behavior, 2002
• Effekte von Topiramat bei Patienten mit Epilepsie und intellektueller Beeinträchtigung
  Der Nervenarzt, 2002
• Efficacy of Levetiracetam: A Review of Three Pivotal Clinical Trials
  Epilepsia, 2001
• A Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy: Report of the ILAE Task Force on Classification and Terminology
  Epilepsia, 2001
• Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating Monotherapy
  Epilepsia, 2000
• Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures
  Epilepsia, 2000
• Levetiracetam for partial seizures
  Neurology, 2000
• A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy
  Seizure, 2000
• Lamotrigine in multihandicapped therapy-resistant epileptic patients.
  Clinical Drug Investigation, 1998